期刊的影响因子--文章列表

期刊文章列表
陈赟，解可波，陈日道，陈大伟，刘继梅，韩耀天，刘雨雨，戴均贵（中国医学科学院北京协和医学院药物研究所中国医学科学院酶与天然药物生物催化重点实验室创新药物非临床药物代谢及PK/PD研究北京市重点实验室卫健委天然药物生物合成重点实验室天然药物活性物质与功能国家重点实验室）.重组人源葡萄糖醛酸转移酶表达系统的构建及应用[J].药学学报,2021,第6期张芳，王晓良（中国医学科学院北京协和医学院药物研究所）.血液载脂蛋白作为神经退行性疾病潜在生物标志物的研究[J].药学学报,2021,第6期朱子玉，姜剑伟，张建军（中国医学科学院北京协和医学院药物研究所新药作用机制研究和药效评价北京市重点实验室）.Torpor发生机制最新研究进展[J].药学学报,2021,第6期卫智权¹，包传红²，陈仪新²，阎莉¹（广西中医药大学广西高校壮医方药基础与应用研究重点实验室；广西中医药大学广西中药药效研究重点实验室）.青藤碱增加配对免疫球蛋白受体B表达抑制巨噬细胞经典活化[J].药学学报,2021,第6期 Anh Tran Thi Van，Mostafa Alilou，Rao Zhigang，Pace Simona，Schwaiger Stefan，Kretzer Christian，Temml Veronika，Giesel Carsten，Jordan Paul M，Bilancia Rossella，Weinigel Christina，Rummler Silke，Waltenberger Birgit，Hung Tran，Rossi Antonietta，Stuppner Hermann，Werz Oliver，Koeberle Andreas.From Vietnamese plants to a biflavonoid that relieves inflammation by triggering the lipid mediator class switch to resolution[J].药学学报,2021,第6期 Ding Lili，Yang Qiaoling，Zhang Eryun，Wang Yangmeng，Sun Siming，Yang Yingbo，Tian Tong，Ju Zhengcai，Jiang Linshan，Wang Xunjiang，Wang Zhengtao，Huang Wendong，Yang Li.Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice[J].药学学报,2021,第6期 Su Lihua，Zhang Xintian，Ma Yunbao，Geng Changan，Huang Xiaoyan，Hu Jing，Li Tianze，Tang Shuang，Shen Cheng，Gao Zhen，Zhang Xuemei，Chen Jijun.New guaiane-type sesquiterpenoid dimers from Artemisia atrovirens and their antihepatoma activity[J].药学学报,2021,第6期 Song Xiaojun，Lv Jianming，Cao Zhiqin，Huang Huiyun，Chen Guodong，Awakawa Takayoshi，Hu Dan，Gao Hao，Abe Ikuro，Yao Xinsheng.Extensive expansion of the chemical diversity of fusidane-type antibiotics using a stochastic combinational strategy[J].药学学报,2021,第6期 Chen Zhen，Mori Wakana，Rong Jian，Schafroth Michael A，Shao Tuo，Van Richard S，Ogasawara Daisuke，Yamasaki Tomoteru，Hiraishi Atsuto，Hatori Akiko，Chen Jiahui，Zhang Yiding，Hu Kuan，Fujinaga Masayuki，Sun Jiyun，Yu Qingzhen，Collier Thomas L，Shao Yihan，Cravatt Benjamin F，Josephson Lee，Zhang Mingrong，Liang Steven H.Development of a highly-specific ~(18)F-labeled irreversible positron emission tomography tracer for monoacylglycerol lipase mapping[J].药学学报,2021,第6期赵娜，石靖（国家药品监督管理局药品审评中心）.口服固体仿制药体外一致性评价中的非常规研究及常见问题解析[J].药学学报,2021,第6期 He Shipeng，Ma Junhui，Fang Yuxin，Liu Ying，Wu Shanchao，Dong Guoqiang，Wang Wei，Sheng Chunquan.Homo-PROTAC mediated suicide of MDM2 to treat non-small cell lung cancer[J].药学学报,2021,第6期 Wang Ying，Zhang Jiaojiao，Cao Xinyu，Guan Yaya，Shen Shuang，Zhong Genshen，Xiong Xiwen，Xu Yanhong，Zhang Xiaoying，Wang Hui，Ye Jianping.Mitochondrial protein IF1 is a potential regulator of glucagon-like peptide (GLP-1) secretion function of the mouse intestine[J].药学学报,2021,第6期 Xu Haiyu，Zhang Yanqiong，Wang Ping，Zhang Junhong，Chen Hong，Zhang Luoqi，Du Xia，Zhao Chunhui，Wu Dan，Liu Feng，Yang Hongjun，Liu Changxiao.A comprehensive review of integrative pharmacology-based investigation:A paradigm shift in traditional Chinese medicine[J].药学学报,2021,第6期 Li Quanjie，Yi Dongrong，Lei Xiaobo，Zhao Jianyuan，Zhang Yongxin，Cui Xiangling，Xiao Xia，Jiao Tao，Dong Xiaojing，Zhao Xuesen，Zeng Hui，Liang Chen，Ren Lili，Guo Fei，Li Xiaoyu，Wang Jianwei，Cen Shan.Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase[J].药学学报,2021,第6期 Wang Zhiqiang，Zhang Zhibo，Li Yong，Sun Li，Peng Dezhen，Du Danyu，Zhang Xian，Han Luwei，Zhao Liwen，Lu Ligong，Du Hongzhi，Yuan Shengtao，Zhan Meixiao.Preclinical efficacy against acute myeloid leukaemia of SH1573, a novel mutant IDH2 inhibitor approved for clinical trials in China[J].药学学报,2021,第6期 Zou Jie，Zhu Xiaoyun，Xiang Dejuan，Zhang Yanqiu，Li Jie，Su Zhigui，Kong Lingyi，Zhang Hao.LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase[J].药学学报,2021,第6期 Tian Wei，Li Jiatong，Wang Zhuo，Zhang Tong，Han Ying，Liu Yanyan，Chu Wenfeng，Liu Yu，Yang Baofeng.HYD-PEP06 suppresses hepatocellular carcinoma metastasis, epithelialemesenchymal transition and cancer stem cell-like properties by inhibiting PI3K/AKT and WNT/beta-catenin signaling activation[J].药学学报,2021,第6期 Zhang Hong，Fu Liwu.The role of ALDH2 in tumorigenesis and tumor progression:Targeting ALDH2 as a potential cancer treatment[J].药学学报,2021,第6期 Liu Ying，Song Zan，Liu Yajie，Ma Xubin，Wang Wang，Ke Yu，Xu Yichao，Yu Dequan，Liu Hongmin.Identification of ferroptosis as a novel mechanism for antitumor activity of natural product derivative a2 in gastric cancer[J].药学学报,2021,第6期 Xie Qin，Ding Jian，Chen Yi.Role of CD8~+ T lymphocyte cells:Interplay with stromal cells in tumor microenvironment[J].药学学报,2021,第6期 Liu Yani，Liu Zongtao，Wang KeWei.The Ca~(2+)-activated chloride channel ANO1/TMEM16A:An emerging therapeutic target for epithelium-originated diseases?[J].药学学报,2021,第6期 Yu Yang，Yao Changliang，Guo De'an.Insight into chemical basis of traditional Chinese medicine based on the state-of-the-art techniques of liquid chromatography-mass spectrometry[J].药学学报,2021,第6期张智新¹，汪逗逗¹，杨林¹，田少凯¹，肖瑶²，刘颖¹（北京中医药大学生命科学学院；北京中医药大学中药学院）.基于基因过表达及基因沉默解析F5H基因对甘草酸生物合成的调控研究[J].药学学报,2021,第6期郭宗儒（中国医学科学院、北京协和医学院药物研究所）.首创的选择性雌激素受体调节剂他莫昔芬[J].药学学报,2021,第6期 Xie Jiashu，Wang Zhengqiang.Can remdesivir and its parent nucleoside GS- 441524 be potential oral drugs? An in vitro and in vivo DMPK assessment[J].药学学报,2021,第6期 Dahlgren David，Olander Tobias，Sjoblom Markus，Hedeland Mikael，Lennernas Hans.Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats[J].药学学报,2021,第6期 Serwetnyk Michael A，Blagg Brian S J.The disruption of proteinLprotein interactions with co-chaperones and client substrates as a strategy towards Hsp90 inhibition[J].药学学报,2021,第6期王雅蒙，邹丹璐，李钰，柯学（中国药科大学药学院江苏省纳米药物制备与生物学评价公共服务中心）.十一酸睾酮Ⅲ型脂质制剂体外脂解过程及机制研究[J].药学学报,2021,第6期 Hu Qian，Lyon Christopher J，Fletcher Jesse K，Tang Wenfu，Wan Meihua，Hu Tony Y.Extracellular vesicle activities regulating macrophage- and tissue-mediated injury and repair responses[J].药学学报,2021,第6期首页上一页 12 13 14 15 16 下一页尾页共有24页，转到页

期刊文章列表